GlassScriptPhysician profile
John Michael Dibianco
NPI 1821482845
$13,438.62
in general payments reported to CMS, 2019-2025
13 companies · $6,127 in 2025
The $6,127 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $176 · 2022: $1,600 · 2023: $1,071 · 2024: $4,465 · 2025: $6,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,109 · Food and Beverage: $3,142 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,063 · Travel and Lodging: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,108.50 |
| Food and Beverage | $3,142.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,062.50 |
| Travel and Lodging | $1,349.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Richard Wolf Medical Instruments Corp. | $5,735.75 | 2024-2025 | |
| Boston Scientific Corporation | $2,904.25 | 2022-2025 | General - Kidney Stone Disease, Lithovue |
| Karl Storz Endoscopy-America | $2,096.00 | 2025 | |
| Procept Biorobotics Corporation | $660.23 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Cook Medical LLC | $573.62 | 2021-2025 | Fiber Dust, Litho 150, Resonance |
| Coloplast Corp | $443.16 | 2024-2025 | |
| Ambu INC. | $292.06 | 2023-2024 | |
| Astellas Pharma US INC | $218.28 | 2021-2023 | Xtandi |
| Valencia Technologies Corporation | $155.19 | 2025 | Ecoin Device Kit |
| Urogen Pharma, INC. | $121.29 | 2023 | Jelmyto |
| Novo Nordisk Health Care Ag | $114.09 | 2024 | |
| Endo USA, INC. | $89.50 | 2025 | Xiaflex |
| Laborie Medical Technologies Corp. | $35.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Michael Dibianco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.